semaglutide south africa sunpharma #semaglutide #glp1 #genericmedicines #southafrica #pharmaceuticals #pharmanews #globalhealth #lifesciences #navlindaily Sun Pharma Gets SAHPRA Nod

It activates AMPK (AMP-activated protein kinase), the same metabolic sensor that metformin targets, which explains the overlapping effects

Discussing Alternative Approaches In addition to laxatives, there are many other methods to manage constipation

According to the trials findings, semaglutide 2.4 mg once a week was considerably more effective than a placebo at helping adults with type 2 diabetes who were overweight or obese lose body weight

The SURMOUNT-5 trial showed that tirzepatide produced 20.2% body weight reduction compared to 13.7% with semaglutide over 72 weeks, a significant gap that suggests tirzepatide may push past the metabolic ceiling where semaglutide stalls